한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제41권3호
  • /
  • Pages.143-149
  • /
  • 2024
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

Investigation of Circulating Cell-Free DNA Concentration in Dogs with Pancreatitis

  • Jae-Hun Kim (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Jeonbuk National University) ;
  • Soo-Yeon Jeong (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Jeonbuk National University) ;
  • Chul Park (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Jeonbuk National University)
  • 투고 : 2024.02.29
  • 심사 : 2024.05.16
  • 발행 : 2024.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Circulating cell-free DNA (cfDNA) constitutes a fragment of DNA released into the blood through cellular apoptosis or necrosis. In human medicine, cfDNA has been studied as a disease severity biomarker. Recent studies have shown that concentrations of cfDNA in dogs with immune-mediated and tumor-related diseases are increased. Pancreatitis is known to be caused by excessive release of trypsin, which leads to edema, inflammation, necrosis, and apoptosis in the pancreas. Based on the results of research showing an increase of cfDNA due to apoptosis and necrosis of cells, we hypothesized that cfDNA concentration would increase in the presence of pancreatitis. A total of 35 dogs were studied, including 21 with pancreatitis and 14 without any inflammatory diseases (normal group). The results showed that the concentration of cfDNA in dogs with pancreatitis was approximately twice that of normal dogs (median 0.0912 ng/μL. p-value 0.028). This result suggests that cfDNA can serve as a new biomarker for estimating pancreatitis severity.

키워드

과제정보

This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry (IPET) through a Companion Animal Life Cycle Industry Technology Development Program funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (322094-03).

참고문헌

  1. Akter S, Nakao R, Imasato Y, Alam MZ, Katakura K. Potential of cell-free DNA as a screening marker for parasite infections in dog. Genomics 2019; 111: 906-912. 
  2. Ettinger SJ, Feldman EC, Cote E. Textbook of veterinary internal medicine. 8th ed. St. Louis: Elsevier Health Sciences. 2017. 
  3. Frank MO. Circulating cell-free DNA differentiates severity of inflammation. Biol Res Nurs 2016; 18: 477-488. 
  4. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61: 1659-1665. 
  5. Jeffery U, Ruterbories L, Hanel R, LeVine DN. Cell-free DNA and DNase activity in dogs with immune-mediated hemolytic anemia. J Vet Intern Med 2017; 31: 1441-1450. 
  6. Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther 2019; 20: 1057-1067. 
  7. Letendre JA, Goggs R. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes. J Vet Emerg Crit Care (San Antonio) 2018; 28: 503-511. 
  8. Letendre JA, Goggs R. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia. J Vet Emerg Crit Care (San Antonio) 2017; 27: 307-314. 
  9. Malin K, Witkowska-Pilaszewicz O. C-reactive protein as a diagnostic marker in dogs: a review. Animals (Basel) 2022; 12: 2888. 
  10. Moreira VG, Prieto B, Rodriguez JSM, Alvarez FV. Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 2010; 47: 253-258. 
  11. Nelson RW, Couto CG. Small animal internal medicine. 6th ed. St. Louis: Elsevier. 2019. 
  12. Penninck D, d'Anjou MA. Atlas of small animal ultrasonography. 2nd ed. Ames: Wiley-Blackwell. 2015: 309-330. 
  13. Poulet G, Massias J, Taly V. Liquid biopsy: general concepts. Acta Cytol 2019; 63: 449-455. 
  14. Promega Corporation. The manual of Maxwell® RSC ccfDNA plasma kit. Madison: Promega Corporation; 2021. 
  15. Ranucci R. Cell-free DNA: applications in different diseases. Methods Mol Biol 2019; 1909: 3-12. 
  16. Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-437. 
  17. Spindler KLG, Demuth C, Sorensen BS, Johansen JS, Nielsen D, Pallisgaard N, et al. Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer. Tumour Biol 2018; 40: 1010428318811207. 
  18. Stark AC, McGrath S, Karn M, Thomson CE. Evaluation of cell-free DNA as a diagnostic marker in cerebrospinal fluid of dogs. Am J Vet Res 2020; 81: 416-421. 
  19. Sun HW, Dai SJ, Kong HR, Fan JX, Yang FY, Dai JQ, et al. Accurate prediction of acute pancreatitis severity based on genome-wide cell free DNA methylation profiles. Clin Epigenetics 2021; 13: 223. 
  20. Tagawa M, Shimbo G, Inokuma H, Miyahara K. Quantification of plasma cell-free DNA levels in dogs with various tumors. J Vet Diagn Invest 2019; 31: 836-843. 
  21. Teo YV, Capri M, Morsiani C, Pizza G, Faria AMC, Franceschi C, et al. Cell-free DNA as a biomarker of aging. Aging Cell 2019; 18: e12890. 
  22. Villiers E, Ristic J. BSAVA manual of canine and feline clinical pathology. 3rd ed. Quedgeley: British Small Animal Veterinary Association (BSAVA). 2016: 126. 
  23. Yamaue H. Innovation of diagnosis and treatment for pancreatic cancer. Singapore: Springer Singapore. 2017.